Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Amyloid-fibril formation Proposed mechanisms and relevance to conformational disease Zerovnik EEur J Biochem 2002[Jul]; 269 (14): 3362-71The phenomenon of the transformation of proteins into amyloid-fibrils is of interest, firstly, because it is closely connected to the so-called conformational diseases, many of which are hitherto incurable, and secondly, because it remains to be explained in physical terms (energetically and structurally). The process leads to fibrous aggregates in the form of extracellular amyloid plaques, neuro-fibrillary tangles and other intracytoplasmic or intranuclear inclusions. In this review, basic principles common to the field of amyloid fibril formation and conformational disease are underlined. Existing models for the mechanism need to be tested by experiment. The kinetic and energetic bases of the process are reviewed. The main controversial issue remains the coexistence of more than one protein conformation. The possible role of oligomeric intermediates, and of domain-swapping is also discussed. Mechanisms for cellular defence and novel therapies are considered.|*Protein Conformation[MESH]|Alzheimer Disease/drug therapy/metabolism[MESH]|Amyloid beta-Peptides/chemistry[MESH]|Amyloid/biosynthesis/*chemistry[MESH]|Amyloidosis/metabolism[MESH]|Animals[MESH]|Humans[MESH]|Kinetics[MESH]|Models, Chemical[MESH]|Nerve Tissue Proteins/*chemistry[MESH]|Neurodegenerative Diseases/drug therapy/*metabolism[MESH]|Neurofibrillary Tangles/*metabolism[MESH]|Plaque, Amyloid/metabolism[MESH]|Prion Diseases/drug therapy/metabolism[MESH]|Protein Folding[MESH]|Protein Structure, Tertiary[MESH]|Structure-Activity Relationship[MESH] |